⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for mercaptopurine

Every month we try and update this database with for mercaptopurine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic LeukemiaNCT02877303
B Acute Lymphob...
B Lymphoblastic...
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Inotuzumab Ozog...
Laboratory Biom...
Mercaptopurine
Methotrexate
Ofatumumab
Prednisone
Rituximab
Vincristine Sul...
14 Years - M.D. Anderson Cancer Center
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic LymphomaNCT01451515
Lymphoblastic L...
Prednisone
Vincristine
Daunorubicin
PEG-asparaginas...
Erwinia asparag...
Doxorubicin
Cyclophosphamid...
Cytarabine
Thioguanine
Clofarabine
Methotrexate
Mercaptopurine
Dexamethasone
Hydrocortisone
Etoposide
- 21 YearsSt. Jude Children's Research Hospital
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in RemissionNCT00268528
Childhood Acute...
Compliance Moni...
Laboratory Biom...
Mercaptopurine
Methotrexate
Questionnaire A...
Study of Socioe...
- 21 YearsChildren's Oncology Group
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)NCT06210750
T Acute Lymphob...
T Lymphoblastic...
Biospecimen Col...
Bone Marrow Asp...
Bone Marrow Bio...
Calaspargase Pe...
Computed Tomogr...
Cyclophosphamid...
Cytarabine
Daunorubicin
Dexamethasone
Doxorubicin
Echocardiograph...
Lumbar Puncture
Mercaptopurine
Methotrexate
Multigated Acqu...
Navitoclax
Nelarabine
Pegaspargase
Positron Emissi...
Thioguanine
Venetoclax
Vincristine
X-Ray Imaging
18 Years - 60 YearsNational Cancer Institute (NCI)
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic LeukemiaNCT00002785
Leukemia
filgrastim
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
mesna
methotrexate
methylprednisol...
pegaspargase
prednisone
therapeutic hyd...
vincristine sul...
allogeneic bone...
low-LET cobalt-...
low-LET photon ...
- 1 YearChildren's Oncology Group
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaNCT00613457
Leukemia
dexamethasone
asparaginase
Asparaginase
cyclophosphamid...
cytarabine
daunorubicin
doxorubicin
Etoposide
Ifosfamide
mercaptopurine
Methotrexate
prednisone
thioguanine
Vincristine
Vindesine
1 Year - 17 YearsAssociazione Italiana Ematologia Oncologia Pediatrica
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaNCT00408005
T Acute Lymphob...
T Lymphoblastic...
Asparaginase
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Nelarabine
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsNational Cancer Institute (NCI)
Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic LymphomaNCT00275106
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
prednisolone
thioguanine
vincristine sul...
radiation thera...
- 21 YearsNational Cancer Institute (NCI)
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic LeukemiaNCT00381680
B-cell Childhoo...
L1 Childhood Ac...
L2 Childhood Ac...
Intermediate Ri...
vincristine sul...
prednisone
doxorubicin hyd...
pegaspargase
cytarabine
methotrexate
dexamethasone
etoposide
cyclophosphamid...
leucovorin calc...
filgrastim
asparaginase
mercaptopurine
1 Year - 29 YearsChildren's Oncology Group
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT00002756
Leukemia
filgrastim
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
leucovorin calc...
mercaptopurine
methotrexate
prednisone
therapeutic hyd...
vincristine sul...
- 1 YearChildren's Oncology Group
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaNCT02101853
Recurrent B Acu...
Allogeneic Hema...
Asparaginase
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Etoposide
Leucovorin Calc...
Mercaptopurine
Methotrexate
Mitoxantrone
Mitoxantrone Hy...
Pegaspargase
Pharmacological...
Radiation Thera...
Therapeutic Hyd...
Thioguanine
Vincristine
Vincristine Sul...
1 Year - 31 YearsNational Cancer Institute (NCI)
Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic LeukemiaNCT03488225
Acute Lymphobla...
B Acute Lymphob...
B Acute Lymphob...
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Inotuzumab Ozog...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Ofatumumab
Prednisone
Rituximab
Vincristine Sul...
16 Years - M.D. Anderson Cancer Center
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT00002744
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
pegaspargase
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
low-LET cobalt-...
low-LET photon ...
1 Year - 9 YearsChildren's Oncology Group
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified TreatmentNCT02881086
Acute Lymphobla...
Lymphoblastic L...
Rituximab
Nelarabine
PEG-Asparaginas...
Cranial irradia...
Imatinib
Idarubicin
Dexamethasone
Cyclophosphamid...
Fludarabine
Vincristine
Mercaptopurine
VP16
Daunorubicin (D...
Methotrexate
Stem cell trans...
Cytarabine
Vindesine
Adriamycin
Prednisolone
18 Years - 55 YearsGoethe University
S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT00109837
Leukemia
filgrastim
cyclophosphamid...
cytarabine
daunorubicin
dexamethasone
doxorubicin
leucovorin
mercaptopurine
methotrexate
mitoxantrone
Asparaginase
prednisone
thioguanine
vincristine
radiation thera...
allopurinol
bactrim
18 Years - 64 YearsSWOG Cancer Research Network
Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaNCT05032183
Recurrent Adult...
Recurrent B Acu...
Recurrent T Acu...
Refractory B Ac...
Refractory Lymp...
Refractory T Ac...
Cyclophosphamid...
Cytarabine
Dexamethasone
Filgrastim-sndz
Leucovorin
Mercaptopurine
Mesna
Methotrexate
Pegfilgrastim
Prednisone
Rituximab
Tagraxofusp-erz...
Vincristine
18 Years - 70 YearsM.D. Anderson Cancer Center
Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic LeukemiaNCT04770922
Acute Lymphobla...
Adverse Drug Ev...
- 21 YearsCipherome, Inc.
Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic LeukemiaNCT03488225
Acute Lymphobla...
B Acute Lymphob...
B Acute Lymphob...
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Inotuzumab Ozog...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Ofatumumab
Prednisone
Rituximab
Vincristine Sul...
16 Years - M.D. Anderson Cancer Center
Different Therapies in Treating Infants With Newly Diagnosed Acute LeukemiaNCT00550992
Leukemia
anti-thymocyte ...
asparaginase
busulfan
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
etoposide
leucovorin calc...
melphalan
mercaptopurine
methotrexate
mitoxantrone hy...
pegaspargase
prednisolone
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
allogeneic bone...
allogeneic hema...
umbilical cord ...
- 1 YearDutch Childhood Oncology Group
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT01256398
Acute Lymphobla...
Adult B Acute L...
Alemtuzumab
Allogeneic Hema...
Autologous Hema...
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Etoposide Phosp...
Filgrastim
Fludarabine Pho...
In Vitro-Treate...
Laboratory Biom...
Leucovorin Calc...
Melphalan
Mercaptopurine
Methotrexate
Pegfilgrastim
Pharmacological...
Tacrolimus
Vincristine Sul...
18 Years - National Cancer Institute (NCI)
Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic LeukemiaNCT02776605
ALL
Prednisone
Vincristine
Daunorubicin
Prednisone
Ponatinib
Mercaptopurine
Methotrexate
VP-16
ARA-C:
TIT
Ponatinib
Autologous tran...
Allo transplant...
18 Years - 55 YearsPETHEMA Foundation
Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and LymphomaNCT01700946
Recurrent B-Cel...
Recurrent Child...
dexamethasone
vincristine sul...
rituximab
clofarabine
cyclophosphamid...
etoposide
aldesleukin
pegaspargase
methotrexate
mercaptopurine
cytarabine
mitoxantrone
teniposide
vinblastine
natural killer ...
laboratory biom...
therapeutic hyd...
allogeneic hema...
CliniMACS
- 21 YearsSt. Jude Children's Research Hospital
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaNCT00002704
Leukemia
filgrastim
asparaginase
cyclophosphamid...
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
liposomal cytar...
mercaptopurine
mesna
methotrexate
therapeutic hyd...
thiotepa
vincristine sul...
low-LET electro...
low-LET photon ...
- 20 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive MutationsNCT02883049
B Acute Lymphob...
B Acute Lymphob...
Central Nervous...
Testicular Leuk...
Clofarabine
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Etoposide
Hydrocortisone ...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 31 YearsNational Cancer Institute (NCI)
Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in BrazilNCT05959720
Acute Lymphoid ...
Minimal Residua...
Gene Abnormalit...
Chemotherapeuti...
Prednisone
Vincristin
Daunorubicin
Peg-asparaginas...
Intrathecal Sus...
Cyclophosphamid...
Cytarabine
Mercaptopurine
Methotrexate
Doxorubicin
16 Years - 50 YearsInstituto do Cancer do Estado de São Paulo
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaNCT00002704
Leukemia
filgrastim
asparaginase
cyclophosphamid...
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
liposomal cytar...
mercaptopurine
mesna
methotrexate
therapeutic hyd...
thiotepa
vincristine sul...
low-LET electro...
low-LET photon ...
- 20 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaNCT00408005
T Acute Lymphob...
T Lymphoblastic...
Asparaginase
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Nelarabine
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsNational Cancer Institute (NCI)
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic LymphomaNCT01190930
Acute Lymphobla...
Adult B Lymphob...
Ann Arbor Stage...
Ann Arbor Stage...
Childhood B Acu...
Childhood B Acu...
Childhood B Lym...
Down Syndrome
Hypodiploid B A...
Philadelphia Ch...
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Quality-of-Life...
Questionnaire A...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsChildren's Oncology Group
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT00002744
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
pegaspargase
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
low-LET cobalt-...
low-LET photon ...
1 Year - 9 YearsChildren's Oncology Group
Combination Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaNCT00005603
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
prednisone
thioguanine
vincristine sul...
1 Year - 21 YearsChildren's Oncology Group
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia PositiveNCT00526305
Acute Lymphobla...
Vincristine
Daunorubicin
Prednisone
L-Asparaginase
Mitoxantrone
Cytosine Arabin...
Hydrocortisone
Mercaptopurine
Cyclophosphamid...
Dexamethasone
- 65 YearsPETHEMA Foundation
Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic LeukemiaNCT02776605
ALL
Prednisone
Vincristine
Daunorubicin
Prednisone
Ponatinib
Mercaptopurine
Methotrexate
VP-16
ARA-C:
TIT
Ponatinib
Autologous tran...
Allo transplant...
18 Years - 55 YearsPETHEMA Foundation
Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell NeoplasmNCT04216524
Blastic Plasmac...
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin
Mercaptopurine
Methotrexate
Methylprednisol...
Prednisone
Rituximab
Tagraxofusp-erz...
Venetoclax
Vincristine
18 Years - M.D. Anderson Cancer Center
Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's LymphomaNCT01230983
Cardiac Toxicit...
Leukemia
Lymphoma
asparaginase
cytarabine
dexrazoxane hyd...
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
prednisone
therapeutic hyd...
vincristine sul...
radiation thera...
- 21 YearsChildren's Oncology Group
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive MutationsNCT02883049
B Acute Lymphob...
B Acute Lymphob...
Central Nervous...
Testicular Leuk...
Clofarabine
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Etoposide
Hydrocortisone ...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 31 YearsNational Cancer Institute (NCI)
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified TreatmentNCT02881086
Acute Lymphobla...
Lymphoblastic L...
Rituximab
Nelarabine
PEG-Asparaginas...
Cranial irradia...
Imatinib
Idarubicin
Dexamethasone
Cyclophosphamid...
Fludarabine
Vincristine
Mercaptopurine
VP16
Daunorubicin (D...
Methotrexate
Stem cell trans...
Cytarabine
Vindesine
Adriamycin
Prednisolone
18 Years - 55 YearsGoethe University
Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous LineageNCT04440267
Acute Leukemia ...
vincristine
daunorubicin
cyclophosphamid...
L-Asparaginase
prednisone
mercaptopurine
methotrexate
dexamethasone
Tyrosine kinase...
14 Years - Institute of Hematology & Blood Diseases Hospital, China
Combination Chemotherapy in Treating Adults With Acute Lymphocytic LeukemiaNCT00002531
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
etoposide
ifosfamide
leucovorin calc...
mercaptopurine
methotrexate
mitoxantrone hy...
prednisolone
teniposide
thioguanine
vincristine sul...
vindesine
allogeneic bone...
peripheral bloo...
radiation thera...
15 Years - 65 YearsNational Cancer Institute (NCI)
Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic LeukemiaNCT02036489
Acute Lymphobka...
Vincristine
Daunorubicin
Prednisone
L-asparaginase
Ciclophosphamid...
Metotrexate
ARA-C
Hidrocortisone
Mercaptopurine
VP-16
Dexametasone
15 Years - PETHEMA Foundation
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaNCT02003222
Acute Lymphobla...
B Acute Lymphob...
Allogeneic Hema...
Biospecimen Col...
Blinatumomab
Bone Marrow Asp...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Etoposide
Lumbar Puncture
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Rituximab
Vincristine
Vincristine Sul...
X-Ray Imaging
30 Years - 70 YearsNational Cancer Institute (NCI)
Treatment of High Risk Adult Acute Lymphoblastic LeukemiaNCT00853008
Acute Lymphobla...
Vincristine
Daunorubicin
Prednisone
Mitoxantrone
Cytosine Arabin...
Dexamethasone
Methotrexate (M...
Cytarabine
ASP
Mercaptopurine
Teniposide
Hydrocortisone
16 Years - PETHEMA Foundation
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and LymphomaNCT03117751
Acute Lymphobla...
Acute Lymphobla...
Prednisone
Vincristine
Daunorubicin
Pegaspargase
Erwinase®
Cyclophosphamid...
Cytarabine
Mercaptopurine
Dasatinib
Methotrexate
Blinatumomab
Ruxolitinib
Bortezomib
Dexamethasone
Doxorubicin
Etoposide
Clofarabine
Vorinostat
Idarubicin
Nelarabine
Thioguanine
Asparaginase Er...
Calaspargase Pe...
1 Year - 18 YearsSt. Jude Children's Research Hospital
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT00557193
Acute Lymphobla...
Acute Undiffere...
Childhood T Acu...
Asparaginase
Biospecimen Col...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Echocardiograph...
Etoposide
Filgrastim
Laboratory Biom...
Lestaurtinib
Leucovorin Calc...
Mercaptopurine
Methotrexate
Methylprednisol...
Multigated Acqu...
Pegaspargase
Pharmacological...
Prednisone
Therapeutic Hyd...
Vincristine Sul...
- 1 YearChildren's Oncology Group
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)NCT00131053
Lymphoblastic L...
Methotrexate
Prednisolone
Dexamethasone
Vincristine
Pirarubicin
Cyclophosphamid...
L-asparaginase
Cytarabine
Hydrocortisone
Mercaptopurine
15 Years - 24 YearsJapan Adult Leukemia Study Group
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or TestesNCT00096135
Leukemia
filgrastim
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
methotrexate
pegaspargase
therapeutic hyd...
vincristine sul...
radiation thera...
18 Months - 29 YearsChildren's Oncology Group
Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood LymphomaNCT02141100
Non-Hodgkin Lym...
6-thioguanine
2 Years - 18 YearsRigshospitalet, Denmark
Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic LymphomaNCT00004228
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
prednisone
thioguanine
vincristine sul...
radiation thera...
1 Year - 30 YearsChildren's Oncology Group
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaNCT03914625
B Acute Lymphob...
B Lymphoblastic...
Down Syndrome
Asparaginase Er...
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Mercaptopurine ...
Methotrexate
Pegaspargase
Prednisolone
Prednisone
Radiation Thera...
Radiation Thera...
Thioguanine
Vincristine Sul...
365 Days - 31 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Acute Lymphocytic LeukemiaNCT00002812
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
idarubicin
mercaptopurine
methotrexate
pegaspargase
prednisone
thioguanine
vincristine sul...
radiation thera...
1 Year - 21 YearsChildren's Oncology Group
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaNCT00613457
Leukemia
dexamethasone
asparaginase
Asparaginase
cyclophosphamid...
cytarabine
daunorubicin
doxorubicin
Etoposide
Ifosfamide
mercaptopurine
Methotrexate
prednisone
thioguanine
Vincristine
Vindesine
1 Year - 17 YearsAssociazione Italiana Ematologia Oncologia Pediatrica
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaNCT00061945
Acute Undiffere...
B-cell Adult Ac...
B-cell Childhoo...
L1 Adult Acute ...
L1 Childhood Ac...
L2 Adult Acute ...
L2 Childhood Ac...
Philadelphia Ch...
Philadelphia Ch...
Philadelphia Ch...
T-cell Adult Ac...
T-cell Childhoo...
Untreated Adult...
Untreated Child...
allopurinol
cyclophosphamid...
daunorubicin hy...
vincristine sul...
dexamethasone
asparaginase
filgrastim
imatinib mesyla...
methotrexate
cytarabine
trimethoprim-su...
mercaptopurine
leucovorin calc...
alemtuzumab
acyclovir
laboratory biom...
pharmacological...
15 Years - National Cancer Institute (NCI)
Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaNCT00022126
Leukemia
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
methylprednisol...
pegaspargase
thioguanine
vincristine sul...
allogeneic bone...
radiation thera...
- 1 YearChildren's Oncology Group
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic LeukemiaNCT00003671
Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
leucovorin calc...
mercaptopurine
methotrexate
thioguanine
vincristine sul...
- 18 YearsChildren's Oncology Group
Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic LeukemiaNCT00089349
Recurrent Child...
alemtuzumab
methotrexate
mercaptopurine
- 30 YearsNational Cancer Institute (NCI)
Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic LeukemiaNCT02877303
B Acute Lymphob...
B Lymphoblastic...
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Inotuzumab Ozog...
Laboratory Biom...
Mercaptopurine
Methotrexate
Ofatumumab
Prednisone
Rituximab
Vincristine Sul...
14 Years - M.D. Anderson Cancer Center
A Study Comparing the Combination of Dasatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or Philadelphia Chromosome-Like (Ph-Like) ABL-Class B-Cell Acute Lymphoblastic Leukemia (B-ALL)NCT06124157
B Acute Lymphob...
Biospecimen Col...
Blinatumomab
Bone Marrow Bio...
Calaspargase Pe...
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin
Doxorubicin
Echocardiograph...
Leucovorin
Mercaptopurine
Methotrexate
Multigated Acqu...
Pegaspargase
Prednisolone
Prednisone
Radiation Thera...
Thioguanine
Vincristine
366 Days - 46 YearsNational Cancer Institute (NCI)
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene RearrangementNCT02828358
Acute Leukemia ...
B Acute Lymphob...
Mixed Phenotype...
Azacitidine
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Hydrocortisone ...
Laboratory Biom...
Leucovorin
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Pharmacological...
Prednisolone
Thioguanine
Vincristine
Vincristine Sul...
- 364 DaysNational Cancer Institute (NCI)
Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic LymphomaNCT05303792
B Acute Lymphob...
B Lymphoblastic...
Cyclophosphamid...
Vincristine
Dexamethasone
Inotuzumab Ozog...
Methotrexate
Cytarabine
Methylprednisol...
Rituximab
Prednisone
Mercaptopurine
Doxorubicin
50 Years - Alliance for Clinical Trials in Oncology
Combination Chemotherapy in Treating Patients With Acute Promyelocytic LeukemiaNCT00276601
Leukemia
arsenic trioxid...
cytarabine
daunorubicin hy...
mercaptopurine
methotrexate
tretinoin
5 Years - 74 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Combination Chemotherapy in Treating Patients With Acute Promyelocytic LeukemiaNCT00276601
Leukemia
arsenic trioxid...
cytarabine
daunorubicin hy...
mercaptopurine
methotrexate
tretinoin
5 Years - 74 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaNCT02003222
Acute Lymphobla...
B Acute Lymphob...
Allogeneic Hema...
Biospecimen Col...
Blinatumomab
Bone Marrow Asp...
Bone Marrow Bio...
Cyclophosphamid...
Cytarabine
Daunorubicin
Daunorubicin Hy...
Dexamethasone
Etoposide
Lumbar Puncture
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Rituximab
Vincristine
Vincristine Sul...
X-Ray Imaging
30 Years - 70 YearsNational Cancer Institute (NCI)
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or TestesNCT00096135
Leukemia
filgrastim
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
leucovorin calc...
mercaptopurine
methotrexate
pegaspargase
therapeutic hyd...
vincristine sul...
radiation thera...
18 Months - 29 YearsChildren's Oncology Group
Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic LeukemiaNCT00003934
Adult Acute Mye...
Adult Acute Pro...
Childhood Acute...
Untreated Adult...
Untreated Child...
tretinoin
daunorubicin hy...
cytarabine
mercaptopurine
methotrexate
arsenic trioxid...
- National Cancer Institute (NCI)
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic LeukemiaNCT00381680
B-cell Childhoo...
L1 Childhood Ac...
L2 Childhood Ac...
Intermediate Ri...
vincristine sul...
prednisone
doxorubicin hyd...
pegaspargase
cytarabine
methotrexate
dexamethasone
etoposide
cyclophosphamid...
leucovorin calc...
filgrastim
asparaginase
mercaptopurine
1 Year - 29 YearsChildren's Oncology Group
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaNCT03914625
B Acute Lymphob...
B Lymphoblastic...
Down Syndrome
Asparaginase Er...
Blinatumomab
Cyclophosphamid...
Cytarabine
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Mercaptopurine ...
Methotrexate
Pegaspargase
Prednisolone
Prednisone
Radiation Thera...
Radiation Thera...
Thioguanine
Vincristine Sul...
365 Days - 31 YearsNational Cancer Institute (NCI)
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First RemissionNCT01503632
Acute Lymphobla...
Behavioral Inte...
Compliance Moni...
Laboratory Biom...
Mercaptopurine
Questionnaire A...
Standard Follow...
1 Year - 21 YearsChildren's Oncology Group
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's LymphomaNCT00018954
Leukemia
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
doxorubicin hyd...
etoposide
ifosfamide
mercaptopurine
methotrexate
prednisone
vincristine sul...
conventional su...
radiation thera...
- National Institutes of Health Clinical Center (CC)
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic LeukemiaNCT00002700
Leukemia
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
leucovorin calc...
mercaptopurine
methotrexate
mitoxantrone hy...
prednisolone
prednisone
therapeutic hyd...
vincristine sul...
allogeneic bone...
autologous bone...
radiation thera...
15 Years - 60 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in BrazilNCT05959720
Acute Lymphoid ...
Minimal Residua...
Gene Abnormalit...
Chemotherapeuti...
Prednisone
Vincristin
Daunorubicin
Peg-asparaginas...
Intrathecal Sus...
Cyclophosphamid...
Cytarabine
Mercaptopurine
Methotrexate
Doxorubicin
16 Years - 50 YearsInstituto do Cancer do Estado de São Paulo
Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic LymphomaNCT05303792
B Acute Lymphob...
B Lymphoblastic...
Cyclophosphamid...
Vincristine
Dexamethasone
Inotuzumab Ozog...
Methotrexate
Cytarabine
Methylprednisol...
Rituximab
Prednisone
Mercaptopurine
Doxorubicin
50 Years - Alliance for Clinical Trials in Oncology
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and AdolescentsNCT03020030
Acute Lymphobla...
Pegaspargase
Erwinia asparag...
Cyclophosphamid...
CYTARABINE
DASATINIB
DEXAMETHASONE
Dexrazoxane
Doxorubicin
ETOPOSIDE
HYDROCORTISONE
LEUCOVORIN CALC...
MERCAPTOPURINE
METHOTREXATE
NELARABINE
Vincristine
1 Year - 21 YearsDana-Farber Cancer Institute
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaNCT00075725
Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsChildren's Oncology Group
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaNCT03150693
B Acute Lymphob...
Allopurinol
Cytarabine
Daunorubicin Hy...
Vincristine Sul...
Dexamethasone
Pegylated L-Asp...
Methotrexate
Bone Marrow Asp...
Cyclophosphamid...
Mercaptopurine
Rituximab
Doxorubicin
Thioguanine
Inotuzumab Ozog...
Laboratory Biom...
18 Years - 39 YearsAlliance for Clinical Trials in Oncology
Treatment of High Risk Adult Acute Lymphoblastic LeukemiaNCT00853008
Acute Lymphobla...
Vincristine
Daunorubicin
Prednisone
Mitoxantrone
Cytosine Arabin...
Dexamethasone
Methotrexate (M...
Cytarabine
ASP
Mercaptopurine
Teniposide
Hydrocortisone
16 Years - PETHEMA Foundation
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT00720109
Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Asparaginase
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin Hy...
Dexamethasone
Etoposide
Filgrastim
Hydrocortisone ...
Ifosfamide
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Methotrexate
Methylprednisol...
Pegaspargase
Prednisone
Radiation Thera...
Vincristine Sul...
2 Years - 30 YearsNational Cancer Institute (NCI)
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in RemissionNCT00268528
Childhood Acute...
Compliance Moni...
Laboratory Biom...
Mercaptopurine
Methotrexate
Questionnaire A...
Study of Socioe...
- 21 YearsChildren's Oncology Group
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaNCT01005758
Leukemia
cyclophosphamid...
cytarabine
dexamethasone
doxorubicin hyd...
etoposide phosp...
hydrocortisone ...
imatinib mesyla...
mercaptopurine
methotrexate
methylprednisol...
pegaspargase
prednisolone
prednisone
vincristine sul...
laboratory biom...
radiation thera...
18 Years - 50 YearsNational Cancer Institute (NCI)
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)NCT00866307
Acute Lymphobla...
Adult B Acute L...
Childhood B Acu...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Laboratory Biom...
Mercaptopurine
Methotrexate
Pegaspargase
Prednisone
Prophylactic Cr...
Thioguanine
Vincristine Sul...
1 Year - 30 YearsChildren's Oncology Group
S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic LeukemiaNCT00492856
Leukemia
mercaptopurine
methotrexate
tretinoin
18 Years - 120 YearsSWOG Cancer Research Network
Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaNCT00003700
Leukemia
G-CSF
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
leucovorin calc...
mercaptopurine
methotrexate
prednisone
vincristine sul...
Allopurinol
15 Years - Alliance for Clinical Trials in Oncology
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: